Metformin: An Old Dog with a New Trick?

1Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Idiopathic pulmonary fibrosis (IPF) remains an important medical challenge, but recent translational data have provided clues implicating deficient AMPK signaling in persistently activated myelofibroblasts within fibrotic foci. A new study in Nature Medicine reports that pharmacological activation of AMPK with metformin can reverse established fibrosis by facilitating deactivation and apoptosis of myofibroblasts. Idiopathic pulmonary fibrosis (IPF) remains an important medical challenge, but recent translational data have provided clues implicating deficient AMPK signaling in persistently activated myelofibroblasts within fibrotic foci. A new study in Nature Medicine reports that pharmacological activation of AMPK with metformin can reverse established fibrosis by facilitating deactivation and apoptosis of myofibroblasts.

Cite

CITATION STYLE

APA

dos Santos, C. C., Gopal, B., & Verma, S. (2018, September 4). Metformin: An Old Dog with a New Trick? Cell Metabolism. Cell Press. https://doi.org/10.1016/j.cmet.2018.08.018

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free